BPG is committed to discovery and dissemination of knowledge
Basic Study
Copyright: ©Author(s) 2026.
World J Clin Oncol. Nov 24, 2026; 17(11): 124935
Published online Nov 24, 2026. doi: 10.5306/wjco.124935
Figure 3
Figure 3 HN1 L promotes colorectal cancer tumorigenesis by inhibiting the Hippo pathway. A: Enrichment analysis of differentially expressed genes between the HN1 L-high and HN1 L-low groups in The Cancer Genome Atlas-colorectal cancer (CRC) cohort; B: Association between HN1 L expression and ssGSEA scores for the WNT and Hippo signaling pathways; C: Differential expression of genes involved in the WNT and Hippo signaling pathways. Red indicates upregulated genes, whereas blue indicates downregulated genes; D: Single-cell expression patterns of HN1 L, TAZ, and MOB1 in the GSE132465 dataset; E: Pathway enrichment analysis of differentially expressed genes in HN1 L-overexpressing CRC cells and corresponding controls; F: Protein-protein interaction network of differentially expressed genes associated with HN1 L overexpression; G: Western blot analysis of HN1 L and Hippo pathway-related proteins, including p-MOB1, total YAP, p-YAP at Ser127 and Ser397, and SNAIL, in HN1 L-modified CRC cells; H: Representative immunohistochemical staining of HN1 L and p-YAP in xenograft tissues. OE: Overexpression; NC: Negative control.


Write to the Help Desk